
In 2 pivotal phase 3 studies, all 5 readers hit sensitivity and specificity targets for florquinitau F 18 tau PET, including in patients with early symptomatic Alzheimer disease.
The latest updates in geriatric psychiatry.
Dr Lavretsky discusses her thoughts on the state of geriatric psychiatry from the APA Annual Meeting. She is Professor of Psychiatry at UCLA. She also directs the Late Life Mood, Stress, and Wellness Research Program at the Semel Institute at UCLA. She is an editorial board member of Psychiatric Times.
Further reading:



